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Basophilia is commonly associated with chronic myelogenous leukemia, notably in the
accelerated phase or during blast crisis. It is also associated with other myeloproliferative neo-
plasms. However, its association with acute leukemia is very rare and is described in association
with acute basophilic leukemia and few acute myeloid leukemias (AMLs) with recurrent genetic
abnormalities such as t(6;9)(p23;q34). Herein, we describe the morphological features and dis-
cuss the differential diagnosis of a case of AML with the blasts showing previously unreported
unusual combination of megakaryoblastic and basophilic differentiation along with peripheral
blood and bone marrow basophilia.
 2015 King Faisal Specialist Hospital & Research Centre. Published by Elsevier Ltd. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Basophils are granulocytes that measure 10–15 lm in
diameter with dark blue or purplish coarse cytoplasmic
granules with a multilobed nucleus. They represent less
than 2% (<0.13  109/L) of peripheral blood leukocytes in
adults. Basophilia (basophils > 2%) is seen in a variety ofreactive and neoplastic conditions. It is commonly associ-
ated with chronic myelogenous leukemia (CML), notably in
the accelerated phase or during blast crisis. It is also
associated with other myeloproliferative neoplasms such
as polycythemia vera, idiopathic myelofibrosis, essential
thrombocythemia, and systemic mastocytosis. Its associa-
tion with acute leukemia is however very rare except in
those cases of CML presenting in blast crisis [1]. We herein
describe the morphological features of a unique previously
AML with unusual divergent differentiation 31unreported association of acute myeloid leukemia (AML)
with basophilic and megakaryoblastic differentiation and
basophilia.Case report
A 17-year-old girl presented with fever and abdominal pain
of 1-week duration. The fever was of high grade and inter-
mittent in nature, associated with chills and rigor. The
abdominal pain was associated with watery diarrhea and
vomiting. The patient reported a history of dyspnea on exer-
tion, easy fatigability, palpitation, loss of weight, and appe-
tite during the past 1 month. Physical examination revealed
pallor, mild hepatomegaly, and nonsignificant cervical lym-
phadenopathy. There was no splenomegaly. Imaging studies
of the chest and abdomen showed multiple nodules and pat-
chy consolidation of bilateral lungs, mild bilateral pleural
effusion and pericardial effusion, mild ascites, hep-
atomegaly, and mildly enlarged hilar and mediastinal lymph
nodes. Hemogram revealed anemia (hemoglobin 76 g/L),
normal leukocyte count with blasts (total leukocyte count
4.1  109/L; blasts 2  109/L), basophilia (7%; 0.3  109/
L), and thrombocytopenia (platelet count 78  109/L).
Peripheral blood smear showed 49% blasts, giant platelets,
and circulating micromegakaryocytes. The patient under-
went a bone marrow (BM) examination and biopsy. BM
examination revealed cellular smears with erythroid hyper-
plasia (myeloid:erythroid ratio 1.3:1). Six percent of ery-
throid cells (Fig. 1D) showed megaloblastosis and
dyserythropoiesis in the form of nuclear budding, irregular-
ity, abnormal chromatin clumping, binucleation, and multi-
nucleation as well as periodic Schiff-positive cytoplasmic
globules. There were no ringed sideroblasts. Dysgranu-
lopoiesis was also present in less than 10% of cells.
Megakaryocytes were increased along with numerous
micromegakaryocytes. Blasts constituted 26% of all nucle-Figure 1 (A–C) Bone marrow aspirate smear showing blasts with h
prominent nucleoli, and basophilic granular cytoplasm. There were n
(red arrows), whereas some others show coarse chromatin and scant
megakaryoblasts (A–C; May–Gru¨nwald–Giemsa stain; 100); (D) dy
are positive for myeloperoxidase (myeloperoxidase cytochemical sta
stain; 100).ated cells. Nearly 20% of the blasts were positive for
myeloperoxidase (MPO; Fig. 1E), but were negative for peri-
odic acid Schiff stain on cytochemistry. Thirty percent of
blasts had coarse, dark bluish purple granules, which
showed metachromasia with toluidine blue stain consistent
with basophilic differentiation (Fig. 1A, B, and E), whereas
another 20% of blasts showed morphology suggestive of
megakaryoblasts (Fig. 1A and C). These blasts were negative
for MPO. Mature basophils constituted 10% of all nucleated
cells in the BM. Trephine biopsy showed hypercellular mar-
row spaces with interstitial increase of blasts admixed with
prominent number of erythroid cells. Reticulin stain showed
focal fibrosis amounting to World Health Organization
(WHO) Grade 1 to 2.
A multiparametric flow cytometry (FCM) was then per-
formed. The cells were acquired on BD FACS Canto II and
analyzed using BD FACS Diva software. The antibodies used
were CD1a, CD2, CD3 (cytoplasmic and surface), CD4, CD5,
CD7, CD8, CD10, CD11c, CD13, CD14, CD19, CD20, CD22,
CD33, CD34, CD38, CD41 (surface and cytoplasmic), CD45,
CD61 (surface and cytoplasmic), CD64, CD117, HLA-DR,
kappa, lambda (surface), TCRab, TCRcd, and TdT (BD Bio-
sciences, San Jose, CA, USA). The gated events/cells in the
blast/progenitor region (CD45dim positivity and low side
scatter) constituted nearly 40% of all single events. These
cells showed expression of CD13, CD33, CD34, CD36, CD38,
CD117, and HLA-DR. Approximately 16% of the blasts also
expressed CD41 and CD61, indicating megakaryocytic differ-
entiation. The nonspecific positivity of CD41 and CD61 due to
platelet aggregation on blasts was excluded, as similar num-
bers of megakaryoblasts were detected using cytoplasmic
CD41 and CD61 as well (Fig. 2). The blasts were negative
for CD11c, CD14, CD64, and B- and T-lymphoid cell markers.
Multiplex reverse-transcriptase polymerase chain reaction
and gel electrophoresis performed for various fusion tran-
scripts such as BCR-ABL1 [t(9;22)(q34;q11.2)], RUNX-
RUNX1T1 [t(8;21)(q22;q22)], CBFb-MYH11 [inv(16)], andigh nuclear-cytoplasmic ratio, opened up chromatin, one to two
o Auer rods. Some of the blasts show coarse basophilic granules
y cytoplasm with cytoplasmic blebs (black arrows) suggestive of
serythropoiesis (May–Gru¨nwald–Giemsa stain; 100); (E) blasts
in; 100) and (F) blasts showing metachromasia (toluidine blue
Figure 2 Multiparametric flow cytometry findings. The single events are gated in the blast/progenitor region (CD45dim-low SSC).
The same events are analyzed in subsequent plots, which showed the expression of CD13, CD33, CD34, CD36, and CD117.
Approximately 16% of cells were positive for cytoplasmic CD41 and CD61; 10% cells were positive for myeloperoxidase. The cells
were negative for monocytic markers (CD11c, CD14, and CD64) and B- and T-lymphoid cell markers (not shown). MPO = myeloper-
oxidase; SSC = side scatter.
32 S. Sreedharanunni et al.PML-RARa [t(15;17)] did not show any recurrent molecular
abnormalities. Conventional cytogenetics and karyotyping
could not be performed due to technical reasons. A final
diagnosis of acute myeloid/megakaryocytic leukemia with
basophilia was made. Because of poor general health,
the patient was not deemed fit for complete 3 + 7 induc-
tion therapy, and therefore, she was started on oral
6-thioguanine therapy along with low-dose cytosine arabi-
noside (10 mg/m2 2 times a day for 10 days). However, the
patient did not respond to this therapy and succumbed to
the illness during the induction phase.Discussion
The association of basophilia with AML is very rare. Litera-
ture reports have described its association with acute baso-
philic leukemia and few other AMLs with recurrent genetic
abnormalities such as t(6;9)(p23;q34). Basophilia frequently
accompanies CML in blast crisis; however, it is uncommon in
de novo Philadelphia-positive AML [2]. Acute basophilic leu-
kemia is a distinct entity in the WHO 2008 classification,
where the blasts show primary differentiation toward baso-
phils, and is classified under ‘‘AML, NOS.” The blasts have a
characteristic morphology. They are medium sized with
round or bilobed nucleus, prominent nucleoli, variable num-
ber of coarse basophilic granules positive for metachro-
matic stains, and cytoplasmic vacuoles. These granules
have a characteristic ultrastructure and are negative for
MPO, Sudan black B, chloroacetate esterase, and nonspeci-
fic esterase. AML with specific recurrent cytogenetic abnor-
malities needs to be excluded before making the diagnosisof acute basophilic leukemia [3]. It is important to note that
unlike many other AMLs in which basophilia is noted to be
associated with various translocations, mature basophils
are usually sparse in acute basophilic leukemia. A few cases
described in the literature as acute basophilic leukemia
show basophilia [4]. Acute basophilic leukemia is distinct
from AML with maturation and basophilia. Blasts will be neg-
ative for MPO in the former, whereas they will be positive in
the latter [4].
AMLs with t(6;9)(p23;q34) show basophilia in nearly 60%
of patients. They usually show the morphology of AML with
maturation or acute myelomonocytic leukemia; however,
in these cases, any of the AML subtypes can be seen other
than acute megakaryoblastic leukemia or promyelocytic leu-
kemia. These cases are often associated with multilineage
dysplasia and ringed sideroblasts. They often have a high fre-
quency of FLT3-ITD mutations and have a poor prognosis [3].
Patients with this translocation do not always present with
AML and may present as a case of myelodysplastic syndrome
or CML in blast crisis [5], t(9;22) negative CML, and myelofi-
brosis [6]. Other cytogenetic abnormalities reported in
patients with AML and basophilia include anomalies of the
short arm of chromosome 12 [7,8], t(8;21)(q22;q22) [9,10],
t(X;6)(p11;q23), and novel karyotypes such as [48,XX,+del
(8)(q24.2q24.3), t(21)] [6]. Basophilic differentiation is also
reported in AML with myelodysplasia-related changes and
complex cytogenetic abnormalities [11].
The morphology and immunophenotype of our case
was consistent with AML. However, it showed a unique
previously undescribed morphological combination. A frac-
tion of blasts showed basophilic differentiation suggested
by morphology and metachromatic staining; in addition,
AML with unusual divergent differentiation 33megakaryoblastic differentiation was confirmed by FCM.
There was peripheral blood and BM basophilia. The diver-
gent differentiation of blasts as well as basophilia is
described in CML in blast crisis [12]. The possibility of
CML in blast crisis and de novo AML with t(9;22) and t
(8;21) were excluded by molecular studies. There was
dysgranulopoiesis and dyserythropoiesis, but these did
not amount to more than 50%, which was necessary to
diagnose AML with myelodysplasia-related changes. The
morphological and immunological features fit best with
a diagnosis of AML with basophilia and a divergent differ-
entiation of megakaryoblast. Such heterogeneity probably
depends on the cell of origin of leukemia affected by
various oncogenic events. The identification of such
heterogeneous population of neoplastic cells is likely to
increase in future with increasing use of advanced
immunophenotypic analysis. They might have a significant
impact on the choice of therapeutics, minimal residual
testing, and prognosis. Our report is limited by the lack
of detailed cytogenetic analysis, but we aimed to high-
light this previously unreported heterogenic morphologi-
cal combination of basophilic and megakaryocytic
differentiation of blasts in acute myeloid leukemia.
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